Elevance Health, Inc Earnings

Elevance Health, Inc’s revenue jumped 14.04% since last year same period to $49776Mn in the Q2 2025. On a quarterly growth basis, Elevance Health, Inc has generated 1.81% jump in its revenue since last 3-months.

Elevance Health, Inc’s net profit fell -24.22% since last year same period to $1743Mn in the Q2 2025. On a quarterly growth basis, Elevance Health, Inc has generated -20.16% fall in its net profits since last 3-months.

Elevance Health, Inc’s net profit margin fell -33.55% since last year same period to 3.5% in the Q2 2025. On a quarterly growth basis, Elevance Health, Inc has generated -21.58% fall in its net profit margins since last 3-months.

Elevance Health, Inc’s earning per share (EPS) estimates for the current quarter stand at 4.94 - a -44.87% fall from last quarter’s estimates.

Elevance Health, Inc’s earning per share (EPS) estimates for the current year stand at 4.94.

Elevance Health, Inc’s earning per share (EPS) fell -12.65% since last year same period to 8.84 in the Q2 2025. This indicates that the Elevance Health, Inc has generated -12.65% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Elevance Health, Inc declared 1.71 dividend per share during the earnings announcement for Q2 2025.